Domov › Alzheimerova choroba › New Jersey
Klinické štúdie Alzheimerova choroba v štáte New Jersey
25 štúdií pre Alzheimerova choroba hľadá účastníkov v zariadeniach v štáte New Jersey.
Mestá v štáte New Jersey
Oficiálny text štúdie (anglicky)
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, West Long Branch
Prebieha náborFáza 2
Vek 55 až 90 · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT06887192A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- Bio Behavioral Health, Toms River
Prebieha náborFáza 2
Vek 55 a viac · Všetky pohlavia · Aktualizované 29. 9. 2026 · NCT06540833A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 1664, Princeton
Prebieha náborFáza 3
Vek 55 až 90 · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT06937229A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
- The Cognitive and Research Center of New Jersey - Springfield- Site Number : 8400005, Springfield
Prebieha náborFáza 2
Vek 55 až 85 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07688213A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Advanced Memory Research Institute - CenExel - PPDS, Toms River
Prebieha náborFáza 3
Vek 55 až 90 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT06585787Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- CenExel Research - Toms River, Toms River
Prebieha náborFáza 2
Vek 55 až 80 · Všetky pohlavia · Aktualizované 21. 9. 2026 · NCT06847321Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- The Cognitive and Research Center of New Jersey, Ridgewood
- The Cognitive and Research Center of New Jersey, Springfield
Prebieha náborFáza 3
Vek 50 až 90 · Všetky pohlavia · Aktualizované 21. 9. 2026 · NCT07177352Comparison of Two Group Wellness Interventions for Individuals With Neurologic Conditions and Their Support Persons
- Kessler Foundation, East Hanover
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 21. 9. 2026 · NCT05048966A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- The Cognitive and Research Center of New Jersey, Springfield
- Advanced Clinical Institute, West Long Branch
Prebieha náborFáza 3
Vek 60 až 85 · Všetky pohlavia · Aktualizované 17. 9. 2026 · NCT06976203Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
- Hackensack Medical Center, Hackensack
Prebieha nábor
Vek 50 až 100 · Všetky pohlavia · Aktualizované 17. 9. 2026 · NCT05295615A Postmarketing Study of Lecanemab for the Treatment of Participants With Alzheimer's Disease
- Eisai Trial Site #1, Nutley
Prebieha náborObservačná štúdia
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 16. 9. 2026 · NCT07821658A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- Global Medical Institutes LLC; Princeton Medical Institute, Princeton
Prebieha náborFáza 3
Vek 55 až 90 · Všetky pohlavia · Aktualizované 16. 9. 2026 · NCT07011732A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- Local Institution - 2650, Toms River
Prebieha náborFáza 3
Vek 55 až 90 · Všetky pohlavia · Aktualizované 16. 9. 2026 · NCT07011745Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Local Institution - 0059, Livingston
- Local Institution - 0081, Toms River
Prebieha náborFáza 2
Vek 55 až 90 · Všetky pohlavia · Aktualizované 1. 9. 2026 · NCT06808984A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- The Cognitive and Research Center of New Jersey - Ridgewood ( Site 1064), Ridgewood
- The Cognitive and Research Center of NJ ( Site 1057), Springfield
- CenExel- AMRI ( Site 1018), Toms River
Prebieha náborFáza 2
Vek 50 až 85 · Všetky pohlavia · Aktualizované 26. 8. 2026 · NCT07033494A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- CenExel AMRI, Toms River
Prebieha náborFáza 1
Vek 50 až 85 · Všetky pohlavia · Aktualizované 24. 8. 2026 · NCT06297590A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Advanced Memory Research Institute of New Jersey, Toms River
Prebieha náborFáza 3
Vek 60 až 85 · Všetky pohlavia · Aktualizované 20. 8. 2026 · NCT06976216Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Rutgers-Robert Wood Johnson Medical School, New Brunswick
Prebieha náborFáza 3
Vek 18 až 75 · Všetky pohlavia · Aktualizované 4. 8. 2026 · NCT06563895A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- The Cognitive and Research Center of New Jersey, Springfield
Prebieha náborFáza 3
Vek 55 a viac · Všetky pohlavia · Aktualizované 7. 7. 2026 · NCT07602582A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
- CenExel-HRI, Marlton
Prebieha náborFáza 1Vítaní zdravých dobrovoľníkov
Vek 45 až 85 · Všetky pohlavia · Aktualizované 4. 6. 2026 · NCT06657768A Postmarketing Study of LEQEMBI in South Korean Participants With Alzheimer's Disease
- Eisai Trial Site #1, Nutley
Prebieha náborObservačná štúdia
Vek 19 a viac · Všetky pohlavia · Aktualizované 21. 4. 2026 · NCT06810960Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol
- Nuclear Imaging Institute, Englewood
Prebieha náborFáza 2Vítaní zdravých dobrovoľníkov
Vek 18 až 120 · Všetky pohlavia · Aktualizované 13. 4. 2026 · NCT07012993Exercise to Improve Brain Health in Older African Americans
- Rutgers, The State University of New Jersey - Newark campus, Newark
Prebieha náborFáza 2Vítaní zdravých dobrovoľníkov
Vek 60 a viac · Všetky pohlavia · Aktualizované 20. 2. 2026 · NCT05597124ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults
- Rutgers - Institute for Health, New Brunswick
Prebieha náborFáza 2Vítaní zdravých dobrovoľníkov
Vek 60 a viac · Všetky pohlavia · Aktualizované 6. 2. 2026 · NCT07392723Open-label Extension Study in Participants With Early Alzheimer's Disease
- GSK Investigational Site, Toms River
Prebieha náborFáza 2
Vek 50 až 85 · Všetky pohlavia · Aktualizované 2. 2. 2026 · NCT07105709Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.